↓ Skip to main content

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
163 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd002309.pub4
Pubmed ID
Authors

Chong, Jimmy, Leung, Bonnie, Poole, Phillippa

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea and a reduction in lung function, quality of life and life expectancy. Apart from smoking cessation, there are no other treatments that slow lung function decline. Roflumilast and cilomilast are oral phosphodiesterase 4 (PDE4) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
United States 1 <1%
Italy 1 <1%
Unknown 159 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 23%
Researcher 25 15%
Student > Postgraduate 14 9%
Student > Bachelor 14 9%
Other 11 7%
Other 28 17%
Unknown 33 20%
Readers by discipline Count As %
Medicine and Dentistry 57 35%
Psychology 22 13%
Nursing and Health Professions 11 7%
Social Sciences 10 6%
Engineering 4 2%
Other 16 10%
Unknown 43 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2017.
All research outputs
#1,753,521
of 23,566,295 outputs
Outputs from Cochrane database of systematic reviews
#3,974
of 12,743 outputs
Outputs of similar age
#17,082
of 216,447 outputs
Outputs of similar age from Cochrane database of systematic reviews
#91
of 243 outputs
Altmetric has tracked 23,566,295 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,743 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.1. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 243 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.